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Shao-Jung Li, MD, and Shu-Hsun Chu, MD, Taipei, TaiwanTricuspid valve infective endocarditis (IE) has been man-aged mostly medically.1 Some patients have had repetitivepulmonary emboli, uncontrolled infection, or congestiveheart failure and deserved surgical intervention. The sur-
gical treatment for tricuspid valve IE ranged from vegetectomy to
tricuspid valve replacement.2 For those patients proposed to have
tricuspid valve replacement, the argument in selection of prostheses
has not been settled. However, the advantages of the valvular ho-
mograft are well known.3 Current practices of valve replacement have
extended the use of homografts.4,5 However, use of a pulmonary
homograft in the tricuspid location has not been reported.
Clinical Summary
A 24-year-old man had persistent fever, productive cough, respi-
ratory distress, and general weakness. The chest film revealed
bilateral, patched pulmonary infiltrates. According to his state-
ment, he was an illicit intravenous drug abuser. Blood cultures
revealed Staphylococcus aureus. Tricuspid vegetation of 1.5 cm in
size and moderate-to-severe regurgitation were noted. None of the
left-sided heart valves had involvement. One week after antibiotic
treatment, he remained febrile and experienced shortness of breath.
The surgical indications were recurrent septic pulmonary emboli
and intractable systemic sepsis.
A median sternotomy was applied. Cardiopulmonary bypass
was commenced after aortic and bicaval cannulation. The tricuspid
valve pathology was examined and then resected. Meanwhile, a
34-mm cryopreserved pulmonary homograft had been thawed. The
adventitia and the muscular remnant were trimmed. Six 2-0
pledget-supported Ti-Cron sutures (Sherwood Davis & Geck, St
Louis, Mo) were put inside the right ventricle, and 3 of them were
transmural. These 6 stitches were arranged in a circular fashion
with regular distance. The depth of these stitches from the tricuspid
annulus was the same as the height of the homograft. Then these
stitches brought the homograft down into place (Figure 1). The
annulus of the homograft and tricuspid valve was sewn with
continuous 4-0 Prolene sutures (Figure 2). After we completed the
procedures, the patient was weaned off cardiopulmonary bypass
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The Journal of Thoracsmoothly. Postoperative trans-
esophageal echocardiography
showed good opening and
competence of the homograft.
The patient had resolution of
sepsis and improvement in re-
spiratory status within 48
hours, followed by an unevent-
ful recovery.
Discussion
IE involving the tricuspid valve is common for intravenous drug
abusers. The tricuspid valve is usually involved extensively, and
preservation of the valvular apparatus seems infrequent. For cer-
tain patients, the septic emboli and inflammatory infiltrates have
Figure 1. Arrangement of 6 double-armed, pledgeted sutures in
the right ventricle, 3 of which were transmural. The homograft
was implanted into the right ventricle when these stitches were
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heart failure would be worse after tricuspid valve resection, espe-
cially for those with mild tricuspid valve insufficiency preopera-
Figure 2. Both tricuspid and homograft annuli were simply re-
paired with continuous sutures.tively. Tricuspid valve replacement for this group of patients is
e6 The Journal of Thoracic and Cardiovascular Surgery ● Novemindicated, despite ongoing septicemia. For all valvular substitutes,
a homograft has been considered the best choice in terms of
durability, biocompatibility, and infection control. Freedom from
explantation for leaflet degeneration was 95% at 8 years.3 How-
ever, the decision regarding the choice of prosthesis must be
individualized.
Aortic or pulmonary homografts have been applied in mitral valve
replacement. Therefore we tried to apply this concept in tricuspid IE.
We believed careful surgical techniques could bring the natural and
competent valve into the tricuspid location. The compliant character-
istics of the homograft provided benefits in right ventricular geometry
rather than the rigid housing of prostheses. The competency of the
homograft played an important role in the early postoperative course.
In addition, the homograft carried the best properties for infection
control. All the characteristics justified the procedure.
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